STOCK TITAN
  1. Home
  2. Sec-filings
  3. AMN
  4. [Form 4/A] AMN HEALTHCARE SERVICES INC Amended Insider Trading Activity

AMN Healthcare (AMN) CLO reports RSU vesting, new grant and correction

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4/A

Rhea-AI Filing Summary

AMN Healthcare’s Chief Legal Officer reported several equity award movements on AMN common stock. On January 15, 2026, restricted stock units vested into common shares, and some shares were withheld at $19.55 per share to cover taxes, leaving 23,652 common shares beneficially owned directly.

The filing also shows activity in restricted stock units. Earlier RSU awards vested into common stock, reducing those RSU balances, while a new grant of 19,641 RSUs was received under the AMN Healthcare 2025 Equity Plan, resulting in 19,641 derivative securities beneficially owned. The amendment corrects a prior filing that had overstated RSU holdings by 19,641 units, clarifying that the correct post‑transaction balance is 19,641, not 39,282.

Positive

  • None.

Negative

  • None.
Insider Laughlin Whitney M
Role Chief Legal Officer
Type Security Shares Price Value
Exercise Restricted Stock Units 202 $0.00 --
Exercise Restricted Stock Units 749 $0.00 --
Exercise Restricted Stock Units 3,537 $0.00 --
Grant/Award Restricted Stock Units 19,641 $0.00 --
Exercise Common Stock 202 $0.00 --
Tax Withholding Common Stock 60 $19.55 $1K
Exercise Common Stock 749 $0.00 --
Tax Withholding Common Stock 223 $19.55 $4K
Exercise Common Stock 3,537 $0.00 --
Tax Withholding Common Stock 1,049 $19.55 $21K
Holdings After Transaction: Restricted Stock Units — 0 shares (Direct); Common Stock — 20,698 shares (Direct)
Footnotes (1)
  1. Common stock acquired on the vesting of Restricted Stock Units. Number of shares withheld for tax purposes. The Restricted Stock Units identified in this row were granted pursuant to the AMN Healthcare 2017 Equity Plan. Each Restricted Stock Unit represents a contingent right to receive one share of AMN Common Stock. The Restricted Stock Units identified in this row were granted on January 15, 2023 and vest in three tranches on each of the first, second and third anniversaries of the grant date and the grantee's provision of three periods of credited service. Restricted Stock Units do not have an expiration date. The Restricted Stock Units identified in this row were granted on January 15, 2024 and vest in three tranches on each of the first, second and third anniversaries of the grant date and the grantee's provision of three periods of credited service. The Restricted Stock Units set forth in this row were granted on January 15, 2025 and vest in three tranches on each of the first, second, and third anniversaries of the grant date and the grantee's provision of three periods of credited service. The Restricted Stock Units reflected in this row were granted pursuant to the AMN Healthcare 2025 Equity Plan. Each Restricted Stock Unit represents a contingent right to receive one share of AMN Common Stock. The Restricted Stock Units set forth in this row were granted on January 15, 2026 and vest in three tranches on each of the first, second, and third anniversaries of the grant date and the grantee's provision of three periods of credited service. Due to an administrative error, the Form 4 filed by the reporting person on January 16, 2026, overstated the amount of derivative securities beneficially owned following the reported transaction by 19,641 shares. This Form 4 is being amended and restated to reflect that, following the reported transaction, 19,641 securities were beneficially owned by reporting person, not 39,282 as previously reported.
Form 4 Insider Transactions: What Each Field Means →
SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Laughlin Whitney M
(Last) (First) (Middle)
2999 OLYMPUS BOULEVARD, SUITE 500
(Street)
DALLAS TX 75019
(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
AMN HEALTHCARE SERVICES INC [ AMN ] 		5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
Chief Legal Officer
3. Date of Earliest Transaction (Month/Day/Year)
01/15/2026
4. If Amendment, Date of Original Filed (Month/Day/Year)
01/16/2026 		6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 01/15/2026 M(1) 202 A $0 20,698 D
Common Stock 01/15/2026 F(2) 60 D $19.55 20,638 D
Common Stock 01/15/2026 M(1) 749 A $0 21,387 D
Common Stock 01/15/2026 F(2) 223 D $19.55 21,164 D
Common Stock 01/15/2026 M(1) 3,537 A $0 24,701 D
Common Stock 01/15/2026 F(2) 1,049 D $19.55 23,652 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Restricted Stock Units (3) 01/15/2026 M 202 (4) (5) Common Stock 202 $0 0 D
Restricted Stock Units (3) 01/15/2026 M 749 (6) (5) Common Stock 749 $0 772 D
Restricted Stock Units (3) 01/15/2026 M 3,537 (7) (5) Common Stock 3,537 $0 7,182 D
Restricted Stock Units (8) 01/15/2026 A 19,641 (9) (5) Common Stock 19,641 $0 19,641(10) D
Explanation of Responses:
1. Common stock acquired on the vesting of Restricted Stock Units.
2. Number of shares withheld for tax purposes.
3. The Restricted Stock Units identified in this row were granted pursuant to the AMN Healthcare 2017 Equity Plan. Each Restricted Stock Unit represents a contingent right to receive one share of AMN Common Stock.
4. The Restricted Stock Units identified in this row were granted on January 15, 2023 and vest in three tranches on each of the first, second and third anniversaries of the grant date and the grantee's provision of three periods of credited service.
5. Restricted Stock Units do not have an expiration date.
6. The Restricted Stock Units identified in this row were granted on January 15, 2024 and vest in three tranches on each of the first, second and third anniversaries of the grant date and the grantee's provision of three periods of credited service.
7. The Restricted Stock Units set forth in this row were granted on January 15, 2025 and vest in three tranches on each of the first, second, and third anniversaries of the grant date and the grantee's provision of three periods of credited service.
8. The Restricted Stock Units reflected in this row were granted pursuant to the AMN Healthcare 2025 Equity Plan. Each Restricted Stock Unit represents a contingent right to receive one share of AMN Common Stock.
9. The Restricted Stock Units set forth in this row were granted on January 15, 2026 and vest in three tranches on each of the first, second, and third anniversaries of the grant date and the grantee's provision of three periods of credited service.
10. Due to an administrative error, the Form 4 filed by the reporting person on January 16, 2026, overstated the amount of derivative securities beneficially owned following the reported transaction by 19,641 shares. This Form 4 is being amended and restated to reflect that, following the reported transaction, 19,641 securities were beneficially owned by reporting person, not 39,282 as previously reported.
Remarks:
/s/ Whitney M. Laughlin 01/29/2026
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

Source: View Original Filing on SEC EDGAR

FAQ

What insider transactions did AMN (AMN) report on January 15, 2026?

The Chief Legal Officer reported restricted stock units vesting into AMN common stock on January 15, 2026. Some resulting shares were withheld at $19.55 per share for taxes, and the insider’s directly held AMN common stock position ended at 23,652 shares after these transactions.

How many AMN (AMN) restricted stock units were newly granted in this filing?

The insider received a new grant of 19,641 restricted stock units tied to AMN common stock. These RSUs were granted under the AMN Healthcare 2025 Equity Plan and vest in three annual tranches starting from January 15, 2026, subject to continued credited service.

Why was this AMN (AMN) Form 4 amended and restated?

The amendment corrects an earlier Form 4 filed on January 16, 2026 that overstated derivative securities beneficially owned by 19,641 RSUs. The corrected filing states the insider held 19,641 restricted stock units after the transaction, not 39,282 as previously reported.

How many AMN (AMN) common shares does the insider hold after these transactions?

After the January 15, 2026 transactions, the insider directly beneficially owns 23,652 AMN common shares. This figure reflects RSU vestings that increased holdings and share withholding for taxes that decreased them, as summarized in the non-derivative securities transaction table.

What AMN (AMN) equity plans are referenced in the restricted stock units?

The filing references RSUs granted under the AMN Healthcare 2017 Equity Plan and the AMN Healthcare 2025 Equity Plan. Each restricted stock unit under these plans represents a contingent right to receive one share of AMN common stock upon vesting, subject to service requirements.